Global Multiomics Market - Size, Share, Trends, and Forecast 2026-2032 | AI, Single-Cell Analysis, and Precision Medicine Propel 12.50% CAGR Toward USD 5.98 Billion by 2032
Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Multiomics Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.
The global multiomics market research report provides strategic insight into a sector projected to grow from USD 2.93 billion in 2026 to USD 5.98 billion by 2032, representing a CAGR of 12.50%. It examines the technologies, analytical capabilities, regional conditions, and governance requirements shaping adoption across research and healthcare.
Integrating Biological Data for Deeper Insight
Multiomics combines multiple biological layers to create a more comprehensive view of disease mechanisms, biological variation, therapeutic response, and patient characteristics. Key data categories include:
Market development is influenced by sequencing and mass-spectrometry capabilities, computational infrastructure, data standards, analytical expertise, and access to well-annotated samples. These insights support strategic planning by clarifying which capabilities are essential for scalable and clinically relevant programs.
Transition Toward Integrated Biology
Research is shifting from isolated molecular measurements to workflows connecting multiomics profiles with clinical records, imaging, longitudinal observations, and functional experiments. This transition increases demand for interoperable data models, standardized sample handling, reproducible pipelines, and methods that distinguish biological signals from technical variation.
Spatial and single-cell technologies are also transforming study design by adding cellular and location-specific context. Meanwhile, laboratory automation is improving the management of complex, multi-step workflows.
Artificial Intelligence and Advanced Analytics
Artificial intelligence and machine learning are increasingly applied to:
Effective implementation depends on representative training data, rigorous validation, transparent performance measures, and careful management of batch effects. Understanding these requirements enables organizations to mitigate analytical and regulatory risks while evaluating AI-enabled solutions. AI should remain an analytical aid rather than a substitute for experimental confirmation, clinical judgment, or responsible data governance.
Regional Market Landscape
Regional comparisons provide a practical basis for identifying partnership opportunities and refining market-entry strategies according to local infrastructure, regulation, and data access.
Economic, Political, and Country-Level Dynamics
ASEAN, BRICS, the European Union, G7, GCC, and NATO-aligned markets demonstrate differing levels of research maturity, standardization, and data governance. Collaboration opportunities depend on interoperable infrastructure and appropriate controls for sensitive biological information.
Major national markets-including the United States, China, India, Japan, South Korea, Australia, Canada, Brazil, Mexico, and leading European countries-offer distinct combinations of scientific capacity, population diversity, healthcare integration, and regulatory oversight.
Strategic Priorities for Market Participants
Key Takeaways from This Report
Key Topics Covered:
1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Multiomics Market, by Product Type
7.1. Introduction
7.2. Consumables
7.3. Instruments
7.4. Software and Services
7.4.1. Services
7.4.1.1. Data Analysis
7.4.1.2. Sample Preparation
7.4.2. Software
8. Multiomics Market, by Technology
8.1. Introduction
8.2. Mass Spectrometry
8.3. Microarrays
8.4. qPCR
8.5. Sequencing
8.5.1. Next Generation Sequencing
8.5.2. Sanger Sequencing
9. Multiomics Market, by Application
9.1. Introduction
9.2. Agriculture and Food Testing
9.3. Biomarker Discovery
9.4. Clinical Diagnostics
9.5. Drug Discovery and Development
9.6. Personalized Medicine
10. Multiomics Market, by End User
10.1. Introduction
10.2. Academic and Research Institutes
10.3. Contract Research Organizations
10.4. Hospitals and Diagnostic Laboratories
10.5. Pharmaceutical and Biotechnology Companies
11. Multiomics Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Multiomics Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Multiomics Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. 10x Genomics, Inc.
15.2. Becton, Dickinson and Company
15.3. Berkeley Lights, Inc.
15.4. BGI Genomics Co., Ltd.
15.5. Bio-Rad Laboratories, Inc.
15.6. Bio-Techne Corporation
15.7. Charles River Laboratories International, Inc.
15.8. Danaher Corporation
15.9. Dolomite Bio
15.10. EpiCypher, Inc.
15.11. Illumina, Inc.
15.12. NanoCellect Biomedical, Inc.
15.13. NanoString Technologies, Inc.
15.14. Olink Proteomics AB
15.15. QIAGEN N.V.
15.16. Shimadzu Corporation
15.17. Singleron Biotechnologies GmbH
15.18. Standard BioTools Inc.
15.19. Takara Bio Inc.
15.20. Tempus AI, Inc.
15.21. Thermo Fisher Scientific Inc.
16. Key Experts
LIST OF FIGURES [19]
LIST OF TABLES [293]
For more information about this report visit https://www.researchandmarkets.com/r/9hml0a
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.